• Keymed Biosciences set its board lineup, dated Sept. 6, 2026, with three executive directors, two non-executive directors.
• Three independent non-executive directors named, including Cheuk Kin Stephen Law, who chairs the audit committee.
• Nomination committee chaired by Bo Chen; Xiao-Fan Wang, Yang Ke serve as members.
• Remuneration committee chaired by Xiao-Fan Wang; Changyu Wang, Yang Ke serve as members.
• Audit committee includes Qi Chen, Yang Ke as members under Law’s chairmanship.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keymed Biosciences Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260906-12322346), on September 06, 2026, and is solely responsible for the information contained therein.